Starmer to urge Macron for “one in, one out” migrant swap amid growing pressure over illegal Channel crossings.

Google Deepmind’s offshoot Isomorphic Labs is about to be a milestone: The first AI developed medication should go into the ...

Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered drug in clinical trials and is “staffing up” ...

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Google's Veo 3 AI video generator is now available globally for AI Pro subscribers, a key move in its revamped two-tier ...

There's little unexpected about this, especially as Genie 2, an AI model capable of generating interactive 3D environments, ...

Demis Hassabis, CEO of Google DeepMind, hinted Tuesday evening that Veo 3, Google’s latest video generating model, could ...

Demis Hassabis, CEO of Google’s DeepMind, teased a potentially groundbreaking direction for Google’s latest video-generating AI model, Veo 3, hinting it could someday power interactive video game ...

Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...